Activity of Amikacin, Gentamicin and Kanamycin against Pseudomonas Aeruginosa
- 1 May 1976
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 4 (3) , 165-175
- https://doi.org/10.1177/030006057600400304
Abstract
The activity of amikacin, gentamicin and kanamycin was tested in vitro against clinical isolates of Pseudomonas aeruginosa. Concentrations of the antibiotics in serum and in saline solution were prepared according to serum levels produced in volunteers 15 minutes, 1, 2, and 6 hours after a single intramuscular injection of 500 mg amikacin, 80 mg gentamicin and 500 mg kanamycin. Following isolation of the Pseudomonas strains in cultures, they were incubated and seeded in Mueller-Hinton broth, then 107 dilutions of the organisms were kept in contact with the prepared antibiotic solutions in serum and in saline solution for three hours, the approximate half-life of the antibiotics in serum. Amikacin was active at concentrations seen six hours post-dose, inhibiting growth in a total of 72·5% of seeded plates. Gentamicin was active for only two hours and inhibited growth in 2·5% of the plates. Kanamycin showed no anti-pseudomonal activity.This publication has 3 references indexed in Scilit:
- Activity of BB-K8 (Amikacin) Against Clinical Isolates Resistant to One or More Aminoglycoside AntibioticsAntimicrobial Agents and Chemotherapy, 1974
- Comparative Pharmacokinetics of BB-K8 and Kanamycin in Dogs and HumansAntimicrobial Agents and Chemotherapy, 1973
- Tobramycin and Gentamicin Concentrations in the Serum of Normal and Anephric PatientsAntimicrobial Agents and Chemotherapy, 1973